Topical immunization using a nanoemulsion containing bacterial membrane antigens

Journal of Drug Delivery Science and Technology

Volumn 42, Issue , 2017, Pages 207-214

  Tamayo, Ibai ^a   Gamazo, Carlos ^a   de Souza Rebouças, Juliana ^a   Irache, Juan M ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Antigen; Nanoemulsion; Outer membrane vesicles; Permeation enhancer; Skin; Vaccine

Indexed keywords

ANTIGEN; INTERFERON; INTERLEUKIN 10; LABRASOL; OUTER MEMBRANE PROTEIN; PEROXIDASE; POLYANHYDRIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CYTOKINE RELEASE; DRUG PENETRATION; EPIDERMIS; FEMALE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MOUSE; NANOEMULSION; NONHUMAN; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; SALMONELLA ENTERICA; ZETA POTENTIAL;

EID: 85014131882     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2017.02.009     Document Type: Article

References (45)

1. Balkhy, H.H., El-Beltagy, K.E., El-Saed, A., Sallah, M., Jagger, J., Benchmarking of percutaneous injuries at a teaching tertiary care center in Saudi Arabia relative to United States hospitals participating in the exposure prevention information network. Am. J. Infect. Control. 39 (2011), 560–565.
2. Gyawali, S., Rathore, D.S., Shankar, P.R., Kumar, K.V., Strategies and challenges for safe injection practice in developing countries. J. Pharmacol. Pharmacother. 4:1 (2013), 8–12.
3. Janjua, N.Z., Butt, Z.A., Mahmood, B., Altaf, A., Towards safe injection practices for prevention of hepatitis C transmission in South Asia: challenges and progress. World J. Gastroenterol. 22 (2016), 5837–5852.
4. Council of the European Union Council Directive 2010/32/EU of 10 May 2010 implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU. http://eur-lex.europa.eu/LexU-riServ/LexUriServ.do?uri=OJ: L:2010:134:0066:0072:EN: PDF, 2010 (Accessed 23 November 2016).
5. De Carli, G., Abiteboul, D., Puro, V., The importance of implementing safe sharps practices in the laboratory setting in Europe. Biochem. Med. Zagreb. 24 (2014), 45–56.
6. Saia, M., Hofmann, F., Sharman, J., Abiteboul, D., Campins, M., Burkowitz, J., et al. Needlestick injuries: incidence and cost in the United States, United Kingdom, Germany, France, Italy, and Spain. Biomed. Intern. 1 (2010), 41–49.
7. Huang, C.M., Topical vaccination: the skin as a unique portal to adaptive immune responses. Semin. Immunopathol. 29 (2007), 71–80.
8. Levin, C., Perrin, H., Combadiere, B., Tailored immunity by skin antigen-presenting cells. Hum. Vaccin. Immunother. 11 (2015), 27–36.
9. Haniffa, M., Gunawan, M., Jardine, L., Human skin dendritic cells in health and disease. J. Dermatol. Sci. 77 (2015), 85–92.
10. Gill, H.S., Kang, S.M., Quan, F.S., Compans, R.W., Cutaneous immunization: an evolving paradigm in influenza vaccines. Expert Opin. Drug Deliv. 11 (2014), 615–627.
11. Song, J.M., Kim, Y.C., Compans, E.O.,R.W., Prausnitz, M.R., Kang, S.M., DNA vaccination in the skin using microneedles improves protection against influenza. Mol. Ther. 20:7 (2012), 1472–1480.
12. Levin, Y., Kochba, E., Hung, I., Kenney, R., Intradermal vaccination using the novel microneedle device MicronJet600: past, present, and future. Hum. Vacc. Immunother. 11 (2015), 991–997.
13. Caffarel-Salvador, E., Donnelly, R.F., Transdermal drug delivery mediated by microneedle arrays: innovations and barriers to success. Curr. Pharm. Des. 22 (2016), 1105–1117.
14. Li, N., Peng, L.H., Chen, X., Nakagawa, S., Gao, J.Q., Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo. Int. J. Nanomedicine. 6 (2011), 3241–3250.
15. ®) vesicles for improved drug delivery into and through the skin. Dragicevic, N., Howard, H.I., (eds.) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, 2016, Springer, Berlin, 39–59.
16. Bernardi, D.S., Bitencourt, C., da Silveira, D.S., da Cruz, E.L., Pereira-da-Silva, M.A., Faccioli, L.H., Lopez, R.F., Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles. Nanomedicine 12 (2016), 2439–2448.
17. Liu, Y., Performance studies of particle acceleration for transdermal drug delivery. Med. Biol. Eng. Comput. 44 (2006), 551–559.
18. Polat, B.E., Blankschtein, D., Langer, R., Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs. Expert. Opin. Drug Deliv. 7 (2010), 1415–1432.
19. Gill, H.S., Andrews, S.N., Sakthivel, S.K., Fedanov, A., Williams, I.R., Garber, D.A., et al. Selective removal of stratum corneum by microdermabrasion to increase skin permeability. Eur. J. Pharm. Sci. 38 (2009), 95–103.
20. Jaiswal, M., Dudhe, R., Sharma, P.K., Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech. 5 (2015), 123–127.
21. Zhai, H., Maibach, H.I., Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol. Appl. Skin. Physiol. 14 (2001), 1–10.
22. Solans, C., Izquierdo, P., Nolla, J., Azemar, N., Garcia-Celma, M.J., Nano-emulsions. Curr. Opin. Colloid Interface Sci. 10 (2005), 102–110.
23. Ochoa, J., Irache, J.M., Tamayo, I., Walz, A., DelVecchio, V.G., Gamazo, C., Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice. Vaccine 25 (2007), 4410–4419.
24. Ochoa-Reparaz, J., Sesma, B., Alvarez, M., Jesus, R.M., Irache, J.M., Gamazo, C., Humoral immune response in hens naturally infected with Salmonella Enteritidis against outer membrane proteins and other surface structural antigens. Vet. Res. 35 (2004), 291–298.
25. Gamazo, C., Ochoa-Repáraz, J., Tamayo, I., Camacho, A., Irache, J.M., Development of a bacterial nanoparticle vaccine. Methods Mol. Biol. 1225 (2015), 39–149.
26. Osborn, M.J., Studies on the gram-negative cell wall. I. evidence for the role of 2-keto-3-deoxyoctonate in the lipopolysaccharide of Salmonella Typhimurium. Proc. Natl. Acad. Sci. USA. 50 (1963), 499–506.
27. Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970), 680–685.
28. Towbin, H., Staehelin, T., Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76 (1979), 4350–4354.
29. Ojer, P., Da Costa, M.R., Calvo, J., Salman, H., Lopez de Cerain, A., Gamazo, C., et al. 2010. Spray-drying of poly(anhydride) nanoparticles for drug/antigen delivery. J. Drug Del. Sci. Technol. 20 (2010), 353–359.
30. Agüeros, M., Campanero, M.A., lrache, J.M., Simultaneous quantification of different cyclodextrins and Gantrez by HPLC with evaporative light scattering detection. J. Pharm. Biomed. Anal. 39 (2005), 495–502.
31. Fukunaga, A., Khaskhely, N.M., Sreevidya, C.S., Byrne, S.N., Ullrich, S.E., Dermal dendritic cells, and not langerhans cells, play an essential role in inducing an immune response. J. Immunol. 180 (2008), 3057–3064.
32. Romani, N., Clausen, B.E., Stoitzner, P., Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol. Rev. 234 (2010), 120–141.
33. van Smeden, J., Bouwstra, J.A., Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients. Curr. Probl. Dermatol. 49 (2016), 8–26.
34. Vitorino, C., Sousa, J., Pais, A., Overcoming the skin permeation barrier: challenges and opportunities. Curr. Pharm. Des. 21 (2015), 2698–2712.
35. Brandner, J.M., Importance of tight junctions in relation to skin barrier function. Curr. Probl. Dermatol. 49 (2016), 27–37.
36. Lane, M.E., Skin penetration enhancers. Int. J. Pharm. 447 (2013), 12–21.
37. Baboota, S., Shakeel, F., Ahuja, A., Ali, J., Shafiq, S., Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm. 57 (2007), 315–332.
38. Zhao, J.H., Ji, L., Wang, H., Chen, Z.Q., Zhang, Y.T., Liu, Y., Feng, N.P., Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo. Int. J. Nanomedicine. 6 (2011), 1611–1619.
39. Farage, M.A., Ebrahimpour, A., Steimle, B., Englehart, J., Smith, D., Evaluation of lotion formulations on irritation using the modified forearm-controlled application test method. Skin. Res. Technol. 13 (2007), 268–279.
40. Zhai, H., Maibach, H.I., Occlusion vs. skin barrier function. Skin. Res. Technol. 8 (2002), 1–6.
41. Elshafeey, A.H., Kamel, A.O., Fathallah, M.M., Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: ex-vivo permeation and in-vivo pharmacokinetic studies. Pharm. Res. 26 (2009), 2446–2453.
42. Gee, C.M., Watkinson, A.C., Nicolazzo, J.A., Finnin, B.C., The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans. J. Pharm. Sci. 103 (2014), 909–919.
43. Ntimenou, V., Fahr, A., Antimisiaris, S.G., Elastic vesicles for transdermal drug delivery of hydrophilic drugs: a comparison of important physicochemical characteristics of different vesicle types. J. Biomed. Nanotechnol. 8 (2012), 613–623.
44. Wosicka, H., Cal, K., Targeting to the hair follicles: current status and potential. J. Dermatol Sci. 57 (2010), 83–89.
45. Nohynek, G.J., Lademann, J., Ribaud, C., Roberts, M.S., Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit. Rev. Toxicol. 37 (2007), 251–277.